Index of reports
> Disability (12)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mercaptopurine disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2012-07-02
Patient: female, weighing 64.4 kg (141.7 pounds)
Reactions: Pancreatitis Acute, Weight Decreased, Drug Ineffective, Breast Discharge, Breast Tenderness, Pseudocyst, Anal Fissure
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Remicade
Indication: Colitis Ulcerative
Start date: 2011-01-01
Mercaptopurine
Administration route: Oral
Indication: Colitis Ulcerative
Other drugs received by patient: Estradiol; Hydrocodone Bitartrate; Creon; Pantoprazole Sodium; Asacol; Nortriptyline HCL
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2012-05-25
Patient: female
Reactions: Lung Consolidation, Osteonecrosis, Joint Range of Motion Decreased, Arthralgia, Limb Asymmetry, Gait Disturbance
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Cytarabine
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Daunorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Mercaptopurine
Indication: Acute Lymphocytic Leukaemia
Vincristine Sulfate
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: intrathecal
Indication: Acute Lymphocytic Leukaemia
Oncaspar
Indication: Acute Lymphocytic Leukaemia
Thioguanine
Indication: Acute Lymphocytic Leukaemia
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2012-05-08
Patient: female
Reactions: Pancreatitis Acute, Drug Ineffective, Pseudocyst
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Remicade
Indication: Colitis Ulcerative
Start date: 2011-01-01
Mercaptopurine
Administration route: Oral
Indication: Colitis Ulcerative
Other drugs received by patient: Creon; Nortriptyline HCL; Asacol; Estradiol; Hydrocodone Bitartrate; Pantoprazole Sodium
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2012-04-25
Patient: female
Reactions: Abdominal Pain, Hyperbilirubinaemia, Dyspnoea, Maternal Exposure During Pregnancy, Pyrexia, Abortion Spontaneous, Hyperhidrosis, Fibromyalgia, Arthralgia, Chest Pain, Pollakiuria, Dizziness, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Remicade
Start date: 2002-08-07
Mercaptopurine
Indication: Crohn's Disease
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Remicade
Start date: 2002-10-04
Possible Mercaptopurine side effects in 76 year old male
Reported by a consumer/non-health professional from United States on 2012-04-16
Patient: 76 year old male, weighing 79.4 kg (174.6 pounds)
Reactions: Renal Failure, Activities of Daily Living Impaired, Pyrexia, Headache, Asthenia
Adverse event resulted in: life threatening event, disablity
Drug(s) suspected as cause:
Mercaptopurine
Possible Mercaptopurine side effects in 10 year old female
Reported by a consumer/non-health professional from Japan on 2012-04-05
Patient: 10 year old female, weighing 20.0 kg (44.0 pounds)
Reactions: Gastrointestinal Haemorrhage, Neoplasm Malignant, Cardiac Failure, Anaemia, Pleural Effusion, Transaminases Increased, Generalised Oedema
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Sprycel
Dosage: 07-20apr;01may-22may;29may-11jun;20jun-06jul;17jul-06aug;14aug-03sep;11-24sep. increased to 50mg/day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2009-02-16
Methotrexate
Dosage: 15mg 12jun-26nov09. intrathecal 12mg 5-5feb10
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2009-06-12
End date: 2010-02-05
Mercaptopurine
Dosage: 38mg/d - 12jun09-01jul09 20mg/d - 02jul09-06jul09 10mg/d - 07jul09-08jul09;10-18mg 04sep-ong
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia Recurrent
Start date: 2009-06-12
Interferon Alfa
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-12-07
End date: 2010-05-05
Other drugs received by patient: Famotidine INJ; Panipenem + Betamipron; Meropenem; Voriconazole; Clofarabine; Cefpirome Sulfate; Cyclophosphamide; Etoposide; Ceftazidime; Teicoplanin; Biapenem; Fosfluconazole; Cytarabine; Micafungin Sodium; Tazobactam; Cefpirome Sulfate; Meropenem; Elspar; Hydrocortisone; Candesartan Cilexetil; Fosfluconazole; Prednisolone; Piperacillin Sodium; Amphotericin B FOR Injection; Amphotericin B; Sulbactam Sodium; Linezolid; Sulfamethoxazole and Trimethoprim; Panipenem
Possible Mercaptopurine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01
Patient: female, weighing 105.2 kg (231.4 pounds)
Reactions: Drug Eruption
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Allopurinol
Administration route: Oral
Indication: Crohn's Disease
Mercaptopurine
Administration route: Oral
Indication: Crohn's Disease
Remicade
Indication: Crohn's Disease
Possible Mercaptopurine side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-02-14
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Evoltra
Dosage: 33 mg, unk
Start date: 2011-07-20
End date: 2011-07-24
Mercaptopurine
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Methotrexate
Dosage: 15 mg, qw
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Evoltra
Dosage: 33 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
Possible Mercaptopurine side effects in female
Reported by a physician from Netherlands on 2012-02-07
Patient: female, weighing 58.8 kg (129.4 pounds)
Reactions: Post Transplant Lymphoproliferative Disorder, Pyrexia
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Methotrexate
Dosage: 15 mg, qw
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Mercaptopurine
Dosage: 50 mg, qd
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-01-12
End date: 2012-01-12
Evoltra
Dosage: 33 mg, unk
Indication: Acute Lymphocytic Leukaemia
Start date: 2010-05-11
End date: 2010-07-24
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2011-11-04
Patient: female
Reactions: Abdominal Pain, Hyperbilirubinaemia, Dyspnoea, Maternal Exposure During Pregnancy, Pyrexia, Hyperhidrosis, Abortion Spontaneous, Arthralgia, Fibromyalgia, Chest Pain, Dizziness, Pollakiuria, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Start date: 2002-08-07
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Remicade
Start date: 2002-10-04
Mercaptopurine
Indication: Crohn's Disease
Possible Mercaptopurine side effects in female
Reported by a physician from United States on 2011-10-19
Patient: female
Reactions: Abdominal Pain, Dyspnoea, Hyperbilirubinaemia, Maternal Exposure During Pregnancy, Pyrexia, Abortion Spontaneous, Hyperhidrosis, Fibromyalgia, Arthralgia, Chest Pain, Dizziness, Pollakiuria, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Start date: 2002-08-07
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Mercaptopurine
Indication: Crohn's Disease
Remicade
Start date: 2002-10-04
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Possible Mercaptopurine side effects in female
Reported by a consumer/non-health professional from United States on 2011-10-14
Patient: female
Reactions: Abdominal Pain, Dyspnoea, Hyperbilirubinaemia, Maternal Exposure During Pregnancy, Pyrexia, Abortion Spontaneous, Hyperhidrosis, Arthralgia, Fibromyalgia, Chest Pain, Dizziness, Pollakiuria, Demyelination
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Remicade
Start date: 2003-06-12
End date: 2003-01-01
Remicade
Start date: 2002-08-07
Remicade
Dosage: four doses received
Indication: Crohn's Disease
Start date: 1999-08-25
Mercaptopurine
Indication: Crohn's Disease
Remicade
Start date: 2002-10-04
|